Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.
Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, Swiss Federal Institute of Technology, 8093 Zurich, Switzerland.
J Am Chem Soc. 2023 Aug 23;145(33):18276-18285. doi: 10.1021/jacs.3c03212. Epub 2023 Aug 9.
An increasing number of cases where amyloids of different proteins are found in the same patient are being reported. This observation complicates diagnosis and clinical intervention. Amyloids of the amyloid-β peptide or the protein α-synuclein are traditionally considered hallmarks of Alzheimer's and Parkinson's diseases, respectively. However, the co-occurrence of amyloids of these proteins has also been reported in patients diagnosed with either disease. Here, we show that soluble species containing amyloid-β can induce the aggregation of α-synuclein. Fibrils formed under these conditions are solely composed of α-synuclein to which amyloid-β can be found associated but not as part of the core of the fibrils. Importantly, by global kinetic analysis, we found that the aggregation of α-synuclein under these conditions occurs via heterogeneous primary nucleation, triggered by soluble aggregates containing amyloid-β.
越来越多的病例报告显示,同一患者体内存在不同蛋白质的淀粉样蛋白。这一观察结果使诊断和临床干预变得复杂。淀粉样-β肽或蛋白α-突触核蛋白的淀粉样蛋白通常被认为分别是阿尔茨海默病和帕金森病的标志。然而,这些蛋白质的淀粉样蛋白也在被诊断患有任何一种疾病的患者中同时出现。在这里,我们表明含有淀粉样-β的可溶性物质可以诱导α-突触核蛋白的聚集。在这些条件下形成的纤维仅由α-突触核蛋白组成,可以发现淀粉样-β与之相关联,但不是纤维核心的一部分。重要的是,通过全局动力学分析,我们发现这些条件下α-突触核蛋白的聚集是通过含有淀粉样-β的可溶性聚集体引发的不均匀初级成核来发生的。